Certified by Founder Lodge
GelMEDIX
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $13,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
GelMEDIX is a biotechnology company developing regenerative medicines committed to combatting vision loss with our groundbreaking biomaterials platform.
Our lead program is focused on
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 18 ,2026 | Seed | $13,000,000 |
Safar Partners
HTL Biotechnology
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
